{"schema_version":"1","generated_at":"2026-11-02T09:01:46.800Z","data_as_of":null,"url":"https://www.findmykol.com/kol/srinivas-devarakonda","json_url":"https://www.findmykol.com/kol/srinivas-devarakonda/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"srinivas-devarakonda","name":"Srinivas Devarakonda","credential":"MD","specialty":"Hematology","specialty_raw":"Hematology","therapeutic_area":"Hematology","therapeutic_areas":["Hematology"],"institution":"The Ohio State University Comprehensive Cancer Center","institution_url":"https://www.findmykol.com/institution/the-ohio-state-university","city":"Columbus","state":"OH","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1154595049","orcid":"0000-0002-8838-1025","openalex":"A5014248827"},"summary":"Srinivas Devarakonda is a Hematology physician affiliated with The Ohio State University Comprehensive Cancer Center. OpenAlex indexes 149 publications with 1,271 citations (h-index 16); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Hematology"]},"scholarship":{"works_count":149,"cited_by_count":1271,"h_index":16,"latest_activity_year":2026,"source":"works"},"trials":{"count":1,"shown":1,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT04205240","title":"Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma","phase":"PHASE2","status":"TERMINATED","role":"Overall official","sponsor":"Srinivas Devarakonda","source_url":"https://clinicaltrials.gov/study/NCT04205240","trial_url":"https://www.findmykol.com/trial/NCT04205240"}],"source":"trials"},"payments":{"company_count":9,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"Adaptive Biotechnologies Corporation","program_year":2025,"amount_usd":39.99,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154595049"},{"payer":"Gilead Sciences, Inc.","program_year":2025,"amount_usd":33.99,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154595049"},{"payer":"Regeneron Healthcare Solutions, Inc.","program_year":2025,"amount_usd":21.43,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1154595049"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1154595049","source":"payments"},"prescribing":{"data_year":2023,"areas_total":1,"areas_shown":1,"areas":[{"area":"Sensory organs","share_pct":100,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":100,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2023,"office_pct":24.8,"facility_pct":75.2},"source":"medicare"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology","year":2026,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2026.0001","status":"verified"},{"title":"NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025","year":2025,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2025.0023","status":"verified"},{"title":"Second primary malignancies following CAR T-cell therapy in patients with hematologic malignancies","year":2025,"journal":"Journal of Hematology & Oncology","source_url":"https://doi.org/10.1186/s13045-025-01676-4","status":"verified"},{"title":"Risk factors and clinical impact of cytomegalovirus DNAemia in patients with multiple myeloma treated with teclistamab","year":2025,"journal":"Blood Neoplasia","source_url":"https://doi.org/10.1016/j.bneo.2025.100097","status":"verified"},{"title":"Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology","year":2024,"journal":"Journal of the National Comprehensive Cancer Network","source_url":"https://doi.org/10.6004/jnccn.2024.0001","status":"verified"}],"source":"works"},"contact":{"address_1":"460 W 10TH AVE","city":"Columbus","state":"OH","zip":"432101240","phone":"614-293-3196","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1154595049","source":"identity"},"similar":[{"name":"Gregory Otterson","slug":"gregory-otterson","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/gregory-otterson","json_url":"https://www.findmykol.com/kol/gregory-otterson/profile.json"},{"name":"Raphael Pollock","slug":"raphael-pollock","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Surgical Oncology","url":"https://www.findmykol.com/kol/raphael-pollock","json_url":"https://www.findmykol.com/kol/raphael-pollock/profile.json"},{"name":"Steven Clinton","slug":"steven-clinton","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/steven-clinton","json_url":"https://www.findmykol.com/kol/steven-clinton/profile.json"},{"name":"Claire Verschraegen","slug":"claire-verschraegen","institution":"The Ohio State University Comprehensive Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/claire-verschraegen","json_url":"https://www.findmykol.com/kol/claire-verschraegen/profile.json"},{"name":"Joseph Antin","slug":"joseph-antin","institution":"Harvard University","specialty":"Hematology","url":"https://www.findmykol.com/kol/joseph-antin","json_url":"https://www.findmykol.com/kol/joseph-antin/profile.json"},{"name":"Scott Kaufmann","slug":"scott-kaufmann","institution":"Mayo Clinic College of Medicine","specialty":"Hematology","url":"https://www.findmykol.com/kol/scott-kaufmann","json_url":"https://www.findmykol.com/kol/scott-kaufmann/profile.json"},{"name":"Jeffrey Miller","slug":"jeffrey-miller","institution":"University of Minnesota Medical School","specialty":"Hematology","url":"https://www.findmykol.com/kol/jeffrey-miller","json_url":"https://www.findmykol.com/kol/jeffrey-miller/profile.json"},{"name":"Ruben Mesa","slug":"ruben-mesa","institution":"Atrium Health Wake Forest Baptist Comprehensive Cancer Center","specialty":"Hematology","url":"https://www.findmykol.com/kol/ruben-mesa","json_url":"https://www.findmykol.com/kol/ruben-mesa/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":11,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2026-02-26","provider_certified":"2026-02-26","collected_at":"2026-11-02T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}